European prazosin market is estimated to decline during the forecast period. Additionally, according to the IHME (Institute for Health Metrics and Evaluation), in Western Europe, there was 3.92% share of the total population that was suffering from depression, 5.71% of the total population had an anxiety disorder and 0.94 % share of the population had […]
Category Archives: Pharmaceuticals
China prazosin market is estimated to decline during the forecast period. China is among the emerging nations facing a burden of the continuous increase in high blood pressure. Lack of physical activity, obese population, alcohol consumption, and smoking are some of the major factors that lead to the increasing incidences of high blood pressure. The […]
Asia-Pacific Prazosin Market is estimated to decline during the forecast period. However, some factors are positively influencing market growth to some extent. According to the European Society of Cardiology (ESC) in 2018, a report presented by a team of scientists suggested that one in five young adults in India has high blood pressure, which equals […]
The global prazosin market is estimated to exhibit a negative CAGR of around 2% during the forecast period. Though the rise in CVDs due to high BP, increasing patient pool, and increasing awareness toward mental care are some of the positive factors for the growth of the market. However, due to the presence of alternative […]
Japan indapamide market is estimated to grow at a CAGR of around 1.7% during the forecast period. The growth is attributed to the rising number of hypertension and diabetes patients in the country. As per the IDF, in 2019, the total cases of diabetes in adults were 7.4 million, which accounted for nearly 7.9% of […]
Indian indapamide market is estimated to grow at a CAGR of around 4.0% during the forecast period owing to the significant prevalence of chronic diseases in the region. According to the Cardiological Society of India, the Trivandrum heart failure registry had registered 1,205 admissions due to heart failure in 2018, of which 834 in men, […]
China indapamide market is estimated to grow at a CAGR of around 4.1% during the forecast period. The market is mainly driven due to growing various heart-related diseases and other diseases in the country. Lack of physical activity, obese population, alcohol consumption, unhealthy diet, and smoking are some major factors leading to the rising number […]
The global indapamide market is estimated to grow significantly at a CAGR of over 2.0% during the forecast period. A significant rise in the incidences of high blood pressure (hypertension) and congestive heart failure is primarily contributing to the growth of the market. High blood pressure affects approximately a third of the adult population across […]
The US urothelial carcinoma market is estimated to grow modestly at a CAGR of around 9.6% during the forecast period. The US contributes significantly to the growth of the urothelial carcinoma treatment market in North America. The healthcare spending of the US is significantly high as compared to that of other regions. The US spends […]
UK urothelial carcinoma market is estimated to grow considerably at a CAGR of around 9.4% during the forecast period. UK has one of the finest healthcare systems in the EU region which enables it to provide quality healthcare to the individual citizens. Urothelial carcinoma is by far the most common form of bladder cancer in […]